|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||3.4000 - 3.7500|
|52 Week Range||2.5700 - 6.6800|
|Beta (3Y Monthly)||1.90|
|PE Ratio (TTM)||30.50|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Capacity expansion, brand building, and supply deals are now in focus, with sales growth expected to really pick up in fiscal 2019.
Results to August 31, 2018 showcase a Canadian leader in low-cost cultivation while growing high-quality indoor product MONCTON, NB , Dec. 14, 2018 /PRNewswire/ - Organigram Holdings Inc. (TSX VENTURE: ...
Organigram reports impressive growth for 2018 in advance of adult recreational sales results
Case in point is Altria Group’s (NYSE:MO) $1.8 billion equity investment in Cronos Group (NASDAQ:CRON). The move features many positive implications, not the least of which is a massive boost for CRON stock. When the deal made headlines, Cronos stock jumped nearly 22% against the prior day’s close.
Earlier in this series, we saw that cannabis stocks’ (SEED) forward EV-to-sales multiples were trading at an all-time low, which was confirmed by the EV-to-EBITDA multiple in the following chart.
California legalized recreational marijuana at the very beginning of 2018. The cannabis industry grows very quickly. Both directly and indirectly, there are a number of ways you can turn cannabis into one of the more intriguing investments in your portfolio.
MONCTON , Dec. 7, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce it has secured a loan from Farm Credit Canada ("FCC") in the amount of $10M , which will be used to finance the expansion of the Company's Moncton campus. The debt is for a term of five years at a variable rate of interest, and currently at 6.70%. The debt is secured against certain assets of Organigram. "Organigram is wholly committed to meeting the significant and growing demand for high quality cannabis across Canada and standing ready to take on new opportunities around the world," says Greg Engel , CEO, Organigram.
3 of the top pot companies investors are watching this week are MedMen Enterprises (MMNFF), OrganiGram Holdings Inc. (OGRMF), and Item 9 Labs Corp. (INLB). Item 9 Labs Corp (INLB) is newly public and undiscovered, with a strong CEO, recent funding to support upcoming ventures, and well-defined expansion plans for 2018 and 2019. It could quickly become a favorite among U.S. and Canadian cannabis investors.
MONCTON, NB , Nov. 30, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce it has been named a silver winner in the Company of the Year - East Canada category in Best in Biz Awards, the only independent business awards program judged each year by prominent editors and reporters from top-tier publications in North America .
HENDERSON, NV / ACCESSWIRE / November 27, 2018 / With the market in a bit of a swoon, many companies with positive 3 rd quarter announcements have not yet seen them baked into the share price properly. ...
MONCTON, NB , Nov. 27, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased announce it has completed the registration process with Saskatchewan Liquor and Gaming Authority (SLGA), making it an official supplier of cannabis for the province. "We are pleased to have been selected as an official supplier of cannabis in Saskatchewan ," says Tim Emberg , Senior Vice President of Sales and Commercial Operations, Organigram.
HEXO (HEXO) has been a strong cannabis player in Canada and its joint venture with Molson Coors makes it one of only two companies to have a partnership with an alcoholic beverage company. Canopy Growth (WEED), who has partnered with Constellation Brands, is the second company. HEXO is also one of the best performers (MJ) so far this year with a YTD return of nearly 30%.
Organigram (OGRMF) is among the few cannabis stocks (HMMJ) with double-digit returns of 19.8% year-to-date as of November 19. In comparison, Cronos Group (CRON) had a return of 2.3%, and HEXO (HEXO) had a return of 30%. Let’s look at how the analysts’ recommendation and price targets have changed.
HENDERSON, NV / ACCESSWIRE / November 20, 2018 / Despite strong sales numbers across the cannabis industry, stocks in the sector have had rough go of it recently. This is most likely due to the overall ...
HENDERSON, NV / ACCESSWIRE / November 16, 2018 / In October, Canada became the first industrialized country in the world to legalize recreational marijuana. Wall Street is calling for upwards of $5 billion ...
MONCTON, NB , Nov. 13, 2018 /CNW/ - The Université de Moncton , in partnership with the Government of Canada , Genome Atlantic, Genome Canada, New Brunswick Innovation Foundation (NBIF) and Organigram Holdings Inc. (TSX VENTURE:OGI) (OGRMF), today announced the creation of an institutional research project focused on cannabis at the Université de Moncton .
HENDERSON, NV / ACCESSWIRE / November 1, 2018 / Last week, Marijuana stocks saw a steep selloff as investors took profits after the big legalization event in Canada. At this point there are plenty of CBD ...
HENDERSON, NV / ACCESSWIRE / October 26, 2018 / After pouring over several companies, we've found a few that look set for a major bounce in conjunction with the market. One company we like a lot that is prime for a rebound is BioRestorative Therapies, Inc. (BRTX) a life sciences company focused on stem cell-based therapies. BRTX looks like it has found that support and is on the brink of its next run.
MONCTON, NB , Oct. 26, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis for the medical and adult-use recreational markets, is pleased to announce that the Company has signed a supply agreement with the Province of British Columbia .
Recreational Cannabis is now officially legal in Canada. In fact, the effects of cannabis have been debated even with the limited evidence procured by the medical community. Due to the fact that marijuana is still federally illegal (being classified as a Schedule 1 drug by the Food and Drug Administration), research is somewhat difficult.
One that is jumping off the screen CleanSpark, Inc. (CLSK). If you look at their recent filings you’ll the company just inked an $18 million-dollar deal with a NYSE company! CLSK is a micro-grid company that owns the patent to the best in class micro grid system for the Cannabis industry. The $18 million-dollar deal with Macerich calls for CLSK to build one of its patented microgrid systems on Macerich’s Thousand Oaks facility in California.